Key result
Transcutaneous auricular vagus nerve stimulation in 21 individuals increased pupil diameter during stimulation ramp-up and increased variability in mean arterial pressure and electrodermal activity.
Why the study?
Although taVNS has shown therapeutic effects in clinical populations, its mechanism and autonomic nervous system responses are not well understood.
Does transcutaneous auricular vagus nerve stimulation alter physiological autonomic responses including pupil diameter, blood pressure, and electrodermal activity in human subjects?
Does transcutaneous auricular vagus nerve stimulation alter physiological autonomic responses including pupil diameter, blood pressure, and electrodermal activity in human subjects?
Transcutaneous auricular vagus nerve stimulation elicits measurable autonomic responses, particularly in pupil diameter, mean arterial pressure, and electrodermal activity, which could serve as biomarkers for treatment optimization.
These Level 5 changes should not guide taVNS use; leaves open validation of pupil and variability measures as biomarkers.
Stimulating the vagus nerve is of great clinical interest, particularly transcutaneous auricular vagus nerve stimulation (taVNS), a noninvasive method of applying current at the cymba conchae of the outer ear to target the auricular branch of the vagus nerve. Recent efforts have shown therapeutic effects of taVNS on clinical populations, but the mechanism and autonomic nervous system (ANS) responses are not well understood. The ANS maintains physiological homeostasis through control of internal organs, including the heart, blood vessels, and pupils. Instead of invasively accessing neural targets, standard clinical measures can record ANS-dependent signals. Twenty-one individuals were tested in four sessions over two weeks; taVNS was applied at the left ear while noninvasive sensors captured electrocardiography, blood pressure, breathing, electrodermal activity (EDA), and pupil diameter (PD). From raw vitals, heart rate, mean arterial pressure (MAP), heart rate variability, EDA, and PD responses were derived and averaged across all participants. Summary statistics showed increased PD during the ramp up period of stimulation and increased variability in MAP and EDA during stimulation that persisted during recovery. These results suggest that transient PD responses could be candidate biomarkers taVNS optimization. Combining multimodal sensors and controlled autonomic testing may provide insight for objective evaluation of treatment efficacy or measurement of disease progression.
No takes yet. Share an insight, caveat, or question.
Debnath et al. (2021) studied this question. Transcutaneous auricular vagus nerve stimulation (taVNS) was evaluated on Physiological responses including pupil diameter, mean arterial pressure, and electrodermal activity. Transcutaneous auricular vagus nerve stimulation in 21 individuals increased pupil diameter during stimulation ramp-up and increased variability in mean arterial pressure and electrodermal activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: